LPCAT4
Lysophospholipid acyltransferase LPCAT4
Also known as: AGPAT7, AYTL3, FLJ10257, LPAAT-eta, LPCT4_HUMAN, LPEAT2, LPLAT10
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q643R3
- Gene
- LPCAT4
- Ensembl
- ENSG00000176454
- Chromosome
- 15
- Canonical length
- 524 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
OverviewNCBI Gene
Members of the 1-acylglycerol-3-phosphate O-acyltransferase (EC 2.3.1.51) family, such as AGPAT7, catalyze the conversion of lysophosphatidic acid (LPA) to phosphatidic acid (PA), a precursor in the biosynthesis of all glycerolipids. Both LPA and PA are involved in signal transduction (Ye et al., 2005 [PubMed 16243729]).[supplied by OMIM, May 2008]
Canonical amino-acid sequenceUniProt
524 residues, UniProt reviewed canonical sequence.
>Q643R3|LPCAT4
1 MSQGSPGDWA PLDPTPGPPA SPNPFVHELH LSRLQRVKFC LLGALLAPIR VLLAFIVLFL
61 LWPFAWLQVA GLSEEQLQEP ITGWRKTVCH NGVLGLSRLL FFLLGFLRIR VRGQRASRLQ
121 APVLVAAPHS TFFDPIVLLP CDLPKVVSRA ENLSVPVIGA LLRFNQAILV SRHDPASRRR
181 VVEEVRRRAT SGGKWPQVLF FPEGTCSNKK ALLKFKPGAF IAGVPVQPVL IRYPNSLDTT
241 SWAWRGPGVL KVLWLTASQP CSIVDVEFLP VYHPSPEESR DPTLYANNVQ RVMAQALGIP
301 ATECEFVGSL PVIVVGRLKV ALEPQLWELG KVLRKAGLSA GYVDAGAEPG RSRMISQEEF
361 ARQLQLSDPQ TVAGAFGYFQ QDTKGLVDFR DVALALAALD GGRSLEELTR LAFELFAEEQ
421 AEGPNRLLYK DGFSTILHLL LGSPHPAATA LHAELCQAGS SQGLSLCQFQ NFSLHDPLYG
481 KLFSTYLRPP HTSRGTSQTP NASSPGNPTA LANGTVQAPK QKGDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LPCAT4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 60 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 60 nTPM
- cerebral cortex: 49 nTPM
- basal ganglia: 46 nTPM
- colon: 40 nTPM
- stomach: 34 nTPM
- esophagus: 33 nTPM
Single-cell type
- foveolar cells: 241 nCPM
- esophageal apical cells: 207 nCPM
- urothelial cells: 114 nCPM
- prostatic hillock cells: 113 nCPM
- colonocytes: 90 nCPM
- retinal ganglion cells: 77 nCPM
Immune cell
- MAIT T-cell: 5.7 nTPM
- T-reg: 4.7 nTPM
- plasmacytoid DC: 3.9 nTPM
- memory CD8 T-cell: 3.5 nTPM
- eosinophil: 3.1 nTPM
- neutrophil: 3 nTPM
Brain region
- cerebral cortex: 84 nTPM
- pons: 58 nTPM
- medulla oblongata: 49 nTPM
- hypothalamus: 48 nTPM
- white matter: 46 nTPM
- thalamus: 42 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.48
- gnomAD missense Z
- 1.55
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- phosphatidic acid biosynthetic process
- phosphatidylcholine acyl-chain remodeling
- phosphatidylethanolamine acyl-chain remodeling
- phosphatidylglycerol acyl-chain remodeling
- phosphatidylserine acyl-chain remodeling
- phospholipid metabolic process
Molecular functions
- 1-acylglycerol-3-phosphate O-acyltransferase activity
- 1-acylglycerophosphocholine O-acyltransferase activity
- 1-acylglycerophosphoethanolamine O-acyltransferase activity
- 1-acylglycerophosphoserine O-acyltransferase activity
- 1-alkylglycerophosphocholine O-acetyltransferase activity
- 2-acylglycerol-3-phosphate O-acyltransferase activity
- lysophosphatidic acid acyltransferase activity
- lysophospholipid acyltransferase activity
- 1-alkenylglycerophosphoethanolamine O-acyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LPCAT4 as an antibody target. Whether an autoantibody or antibody against LPCAT4 could matter depends on whether native LPCAT4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LPCAT4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LPCAT4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...